Korehito Kashiwagi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Korehito Kashiwagi has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Hideki Chiba
Department of Basic Pathology, Fukushima Medical University School of Medicine, Fukushima, Japan.
9 shared publications - Kotaro Sugimoto
Department of Basic Pathology Fukushima Medical University School of Medicine Fukushima Japan
8 shared publications - Keiya Fujimori
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan
7 shared publications - Manabu Kojima
Department of Basic Pathology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan
7 shared publications - Naoki Ichikawa-Tomikawa
Department of Basic Pathology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan
7 shared publications - Shu Soeda
Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, Fukushima, Japan
7 shared publications
Latest Publications
- Open Access
- 18 June 2026
- Published by Elsevier in The American Journal of Pathology
- Vol. 196 (9) , 1839-1854
Dual mechanisms underlie the repression of REST expression in lung neuroendocrine carcinoma cells
- 18 June 2026
- Published by Elsevier in The American Journal of Pathology
- Vol. 196 (9) , 1839-1854
Open AccessDual mechanisms underlie the repression of REST expression in lung neuroendocrine carcinoma cells
- 25 September 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 785, 152710
CLDN4 regulates cell proliferation in small cell lung cancer cells via SAA1 inhibition
- 25 September 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 785, 152710
CLDN4 regulates cell proliferation in small cell lung cancer cells via SAA1 inhibition
- 27 January 2025
- Published by Wiley in Pathology International
- Vol. 75 (2) , 105-113
Spontaneous Transformation from Lung Adenocarcinoma to MYC‐amplified Large Cell Neuroendocrine Carcinoma
Recent studies suggest that lung adenocarcinoma cells are closely associated with the tumorigenesis of large‐cell neuroendocrine carcinoma via cellular transformation. However, morphological evidence, along with genetic abnormalities before, during, and after transformation, is quite limited. We present here a case of combined large‐cell neuroendocrine carcinoma and adenocarcinoma exhibiting acinar and solid patterns. Adenocarcinoma cells with abundant mucin, exhibiting positivity for both napsin‐A and neuroendocrine markers, were partially found in the acinar adenocarcinoma component and extensively observed in the solid adenocarcinoma component. Next‐generation sequencing using extracted genomic DNA from the three components revealed homozygous TP53 (missense) and STK11 (nonsense) mutations in all three components, suggesting monoclonal origin. Furthermore, MYC gene amplification, recently presumed to be a pivotal driver in neuroendocrine transformation, was observed in both the solid adenocarcinoma and large‐cell neuroendocrine carcinoma components. These genetic findings corresponded to pre‐ and post‐transformation morphology, providing compelling evidence that some kinds of adenocarcinomas may serve as a precursor of large‐cell neuroendocrine carcinoma.
- 27 January 2025
- Published by Wiley in Pathology International
- Vol. 75 (2) , 105-113
Spontaneous Transformation from Lung Adenocarcinoma to MYC‐amplified Large Cell Neuroendocrine Carcinoma
Recent studies suggest that lung adenocarcinoma cells are closely associated with the tumorigenesis of large‐cell neuroendocrine carcinoma via cellular transformation. However, morphological evidence, along with genetic abnormalities before, during, and after transformation, is quite limited. We present here a case of combined large‐cell neuroendocrine carcinoma and adenocarcinoma exhibiting acinar and solid patterns. Adenocarcinoma cells with abundant mucin, exhibiting positivity for both napsin‐A and neuroendocrine markers, were partially found in the acinar adenocarcinoma component and extensively observed in the solid adenocarcinoma component. Next‐generation sequencing using extracted genomic DNA from the three components revealed homozygous TP53 (missense) and STK11 (nonsense) mutations in all three components, suggesting monoclonal origin. Furthermore, MYC gene amplification, recently presumed to be a pivotal driver in neuroendocrine transformation, was observed in both the solid adenocarcinoma and large‐cell neuroendocrine carcinoma components. These genetic findings corresponded to pre‐ and post‐transformation morphology, providing compelling evidence that some kinds of adenocarcinomas may serve as a precursor of large‐cell neuroendocrine carcinoma.
- Open Access
The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling
Cell adhesion molecules, including integrins, cadherins, and claudins (CLDNs), are known to activate Src-family kinases (SFKs) that organize a variety of physiological and pathological processes; however, the underlying molecular basis remains unclear. Here, we identify the SFK members that are coupled with the CLDN6-adhesion signaling. Among SFK subtypes, BLK, FGR, HCK, and SRC were highly expressed in F9 cells and concentrated with CLDN6 along cell borders during epithelial differentiation. Immunoprecipitation assay showed that BLK and SRC, but not FGR or HCK, form a complex with CLDN6 via the C-terminal cytoplasmic domain. We also demonstrated, by pull-down assay, that recombinant BLK and SRC proteins directly bind to the C-terminal cytoplasmic domain of CLDN6 (CLDN6C). Unexpectedly, both recombinant SFK proteins recognized the CLDN6C peptide in a phosphotyrosine-independent manner. Furthermore, by comparing phenotypes of F9:Cldn6:Blk−/− and F9:Cldn6:Src−/− cells with those of wild-type F9 and F9:Cldn6 cells, we revealed that BLK and SRC are essential for CLDN6-triggered cellular events, namely epithelial differentiation and the expression of retinoid acid receptor target genes. These results indicate that selective SFK members appear to participate in the CLDN-adhesion signaling.
Open AccessThe Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling
Cell adhesion molecules, including integrins, cadherins, and claudins (CLDNs), are known to activate Src-family kinases (SFKs) that organize a variety of physiological and pathological processes; however, the underlying molecular basis remains unclear. Here, we identify the SFK members that are coupled with the CLDN6-adhesion signaling. Among SFK subtypes, BLK, FGR, HCK, and SRC were highly expressed in F9 cells and concentrated with CLDN6 along cell borders during epithelial differentiation. Immunoprecipitation assay showed that BLK and SRC, but not FGR or HCK, form a complex with CLDN6 via the C-terminal cytoplasmic domain. We also demonstrated, by pull-down assay, that recombinant BLK and SRC proteins directly bind to the C-terminal cytoplasmic domain of CLDN6 (CLDN6C). Unexpectedly, both recombinant SFK proteins recognized the CLDN6C peptide in a phosphotyrosine-independent manner. Furthermore, by comparing phenotypes of F9:Cldn6:Blk−/− and F9:Cldn6:Src−/− cells with those of wild-type F9 and F9:Cldn6 cells, we revealed that BLK and SRC are essential for CLDN6-triggered cellular events, namely epithelial differentiation and the expression of retinoid acid receptor target genes. These results indicate that selective SFK members appear to participate in the CLDN-adhesion signaling.